MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Conference call to provide corporate updates today at 4:30 pm ET2024 revenues of 77M, +31% v. 4Q 20232024 net income of 68M 4Q 2024 net income of 23MReduced debt principal by 36MYear-end 2024 cash, cash equivalents and investments of $203MAdvanced pipeline: Reported primary endpoint of INHALE-1 for Afrezza in pediatricsProgressed MNKD-101 to Global Phase 3Completed Phase ...